Ludwig-Maximilians-Universität, Chair of Metabolic Biochemistry

Breadcrumb Navigation


Science Translational Medicine: Loss of function of TREM2, a key receptor selectively expressed by microglia in the brain, contributes to the development of Alzheimer’s disease (AD). We therefore examined whether soluble TREM2 (sTREM2) concentrations in cerebrospinal fluid (CSF) were associated with reduced rates of cognitive decline and clinical progression in subjects with AD or mild cognitive impairment (MCI). more

The “Hartwig Piepenbrock-DZNE Prize” is awarded every two years by the Company Piepenbrock and the German Center for Neurodegenerative Diseases (DZNE) for outstanding research on neurodegenerative diseases. This year it goes to the Alzheimer's researcher Christian Haass in Munich. more